BY CHRISTOPHER DUE KARLSSON
-
Deutsche Bank: An acquisition of Zealand Pharma is not unthinkable
Nonetheless, the financial institution additionally describes the chance of an acquisition as being on the low aspect.
-
Leo Pharma owners “fully support” firm despite cost and job cuts
According to Leo Pharma’s chief executive officer, the dermatology firm is still delaying substantially behind its rivals when it involves revenues.
-
Despite new layoffs: Leo Pharma CEO does not rule out further measures
For Leo Pharma Chief Executive Officer Christophe Bourdon, it has to do with focusing on sources in the proper way and guaranteeing performance.
-
More layoffs at Leo Pharma: 200 jobs to be cut
One more 50 placements will certainly additionally be relocated to Poland.
-
Leo Pharma files for approval of psoriasis treatment Enstilar in China
It is the possibility of an eye-catching Chinese market that currently leads Leo Pharma to obtain advertising authorisation for Enstilar in China, according to the business’s…
-
Novo Holdings increases investment in India-based global healthcare AI innovator
The cash will likely be spent on accelerating the Indian firm’s enlargement into the US market and different geographical areas.
-
US filing accepted for new growth hope for Leo Pharma
On Monday, the Danish dermatology business additionally obtained last authorization for the exact same medicine in the European Union.
-
How Google Chrome is declaring war against ad blockers
I have actually created a great deal concerning advertisement blockers in the last couple of weeks, from Google’s Chrome updates making some prominent alternatives unusable, …
-
Leo Pharma launches autoinjector for key eczema treatment in the US
Adbry has until now just been readily available by utilizing a pre-filled syringe.
-
Novo Nordisk starts new Phase III study with Wegovy successor
In the brand-new Stage III test, the pharmaceutical business seeks to evaluate reduced dosages of cagrisema, which is anticipated to be the future generation of the business’…